Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis
Donald E. Stull(IQVIA (United States)), L. Puig(Universitat Autònoma de Barcelona), I. Gilloteau(Novartis (Switzerland)), Adriana Guana(Novartis (Switzerland)), Katherine Houghton(RTI Health Solutions), C.E.M. Griffiths(King's College London), A.Y. Finlay(Cardiff University), Yang Zhao(Xi'an Jiaotong University), Bintu Sherif(RTI Health Solutions)
Cited by 12
Related Papers
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
|Clinical and Experimental Dermatology|1994|5.5k
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..
|British Journal of Dermatology|1994|1.3k
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
|British Journal of Dermatology|2010|1k
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
|Journal of Investigative Dermatology|2014|954
Psoriasis
|Nature Reviews Disease Primers|2016|893